Fed. Circ. Axes E8 Pharmaceuticals' Gene Testing IP Claims

Law360, New York (November 6, 2013, 4:53 PM ET) -- The Federal Circuit on Wednesday ruled that Affymetrix Inc. and Navigenics Inc. have not infringed on a patent covering a method for genetic testing held by E8 Pharmaceuticals LLC, offering a full-throated endorsement of the district court's claim construction.

In a brief opinion, the panel said that Massachusetts U.S. District Judge George A. O'Toole had offered an acceptable construction of a key phrase within the patent that describes the method for creating a reduced complexity genome, or RCG, through the use of a polymerase chain reaction....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

E8 Pharmaceuticals, LLC v. Affymetrix, Inc.


Case Number

13-1046

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

October 26, 2012

Law Firms

Companies

Patents

DEWEY LIVE BLOG

Follow our exclusive coverage of the trial of the year:

Catch up on the Dewey trial here